ACM
YARW

ADAR1 Capital Management’s Yarrow Bioscience YARW Stock Holding History

ADAR1 Capital Management’s Portfolio YARW Stock Details YARW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.92M Buy
59,000
+37,722
+177% +$1.22M 0.09% 142
2026
Q1 		$636K Buy
21,278
+16,202
+319% +$473K 0.04% 190
2025
Q4 		$147K Buy
+5,076
New +$102K 0.01% 236
2025
Q2 		– Sell
-1,408
Closed -$111K – 238
2025
Q1 		$111K Buy
+1,408
New +$173K 0.02% 161
2024
Q4 		– Sell
-3,057
Closed -$287K – 304
2024
Q3 		$287K Sell
3,057
-367
-11% -$34.8K 0.05% 146
2024
Q2 		$337K Buy
3,424
+1,222
+55% +$152K 0.06% 118
2024
Q1 		$338K Buy
+2,202
New +$237K 0.08% 97

Other funds holding YARW

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
SC
Shay Capital New York $1.56B AUM 46.17% 1-Year Est. Return
TC
T3 Companies New York $93.7M AUM
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
KCA
KVP Capital Advisors San Francisco, California $136M AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

ADAR1 Capital Management's YARW Position: Q2 2026 in Review

ADAR1 Capital Management increased its Yarrow Bioscience (YARW) stake by 177% in Q2 2026, buying an estimated $1.22M and bringing the position to 59,000 shares worth $1.92M. The position accounts for 0.09% of the portfolio, ranked #142.

ADAR1 Capital Management first reported a position in YARW in Q1 2024 and has held it in 7 quarters since. 40 funds tracked by Wall St. Rank hold YARW as of Q2 2026.

  • ADAR1 Capital Management held 59,000 shares of Yarrow Bioscience worth $1.92M as of Q2 2026.
  • ADAR1 Capital Management bought 37,722 Yarrow Bioscience shares in Q2 2026, an estimated $1.22M.
  • Yarrow Bioscience made up 0.09% of ADAR1 Capital Management's portfolio in Q2 2026, its #142 holding.
  • ADAR1 Capital Management first reported a position in Yarrow Bioscience in Q1 2024 and has held it in 7 quarters since.
  • 40 funds tracked by Wall St. Rank held Yarrow Bioscience as of Q2 2026.

Based on ADAR1 Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.